Hematology & Blood Cancer
Advertisement
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
The clinically focused intervention invovled a symptom assessment questionnaire followed by symptom support.
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit.
Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings.
Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee.
The Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR are taking place February 12-15.
The Lee Symptom Scale for skin sclerosis was informed by patient interviews and feedback.
The study highlights the need for improved patient education and provider communication on early symptoms of cGVHD.
Amy Pierre, RN, BSN, ANP-BC, explains why it's important for advanced practice nurses to be invovled in research.
Pierluigi Porcu, MD, discusses the phase II Tellomak trial and how nurses can help patients manage this rare disease.
Amy Pierre, RN, BSN, ANP-BC, reflects on highlights from ASH 2024 and why it's critical for advanced practitioners to attend.
The CLL12 trial included patients with treatment-naive, asymptomatic, early-stage chronic lymphocytic leukemia.
Researchers evaluated treatment patterns, blood count control, and use of phlebotomy in patients with polycythemia vera.
Lisa Hwa, APRN, CNP, DNP, MS, discusses her work with the ASH Medical Educators Institute and her conference experience.
Amy Pierre, RN, BSN, ANP-BC, shares insights and key action items from her ASH 2024 presentation on the topic.
Richard Newcomb, MD, shares insights from his ASH 2024 presentation and explains why nurses play a major role in outcomes.
Samantha Shenoy, NP, speaks about her experience at the meeting and key highlights in multiple myeloma research.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, explains key takeaways from her myeloma research at ASH 2024.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.